We are live on ! Find out more
BP

Ballentine Partners Portfolio holdings

AUM $8.18B
1-Year Est. Return 27.59%
This Fund
S&P 500
This Quarter Est. Return
+16.96%
1 Year Est. Return
+27.59%
3 Year Est. Return
+76.88%
5 Year Est. Return
+72.28%
10 Year Est. Return
+235.36%
AUM
$8.18B
AUM Growth
+$1B
Cap. Flow
+$26.1M
Cap. Flow %
0.32%
Top 10 Hldgs %
59.27%
Holding
1,129
New
115
Increased
553
Reduced
336
Closed
51

Sector Composition

Rank Sector Weight
1 Miscellaneous 76.26%
2 Technology 8.58%
3 Financials 5.02%
4 Communication Services 2.18%
5 Healthcare 1.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROP icon
901
Roper Technologies
ROP
$40.3B
$247K ﹤0.01%
730
-204
-22% -$69.6K
LEA icon
902
Lear
LEA
$6.64B
$247K ﹤0.01%
1,840
+185
+11% +$24.8K
JHG
903
DELISTED
Janus Henderson
JHG
$246K ﹤0.01%
4,744
+630
+15% +$32.6K
EMN icon
904
Eastman Chemical
EMN
$8.14B
$246K ﹤0.01%
3,675
+830
+29% +$60.7K
MELI icon
905
Mercado Libre
MELI
$100B
$246K ﹤0.01%
145
+9
+7% +$15.4K
AGG icon
906
iShares Core US Aggregate Bond ETF
AGG
$138B
$246K ﹤0.01%
2,482
-90
-3% -$8.9K
LVS icon
907
Las Vegas Sands
LVS
$28.7B
$245K ﹤0.01%
5,308
+51
+1% +$2.65K
QS icon
908
QuantumScape Corp
QS
$3.37B
$245K ﹤0.01%
32,389
+1,421
+5% +$10.7K
NVTS icon
909
Navitas Semiconductor
NVTS
$3.08B
$245K ﹤0.01%
13,664
+183
+1% +$3.49K
MATX icon
910
Matsons
MATX
$6.75B
$244K ﹤0.01%
1,270
+7
+0.6% +$1.28K
TBPH icon
911
Theravance Biopharma
TBPH
$887M
$244K ﹤0.01%
14,362
REPL icon
912
Replimune Group
REPL
$1.42B
$244K ﹤0.01%
22,046
+400
+2% +$2.45K
OXY icon
913
Occidental Petroleum
OXY
$60B
$244K ﹤0.01%
5,015
+228
+5% +$12.9K
CPB icon
914
Campbell Soup
CPB
$6.38B
$242K ﹤0.01%
10,886
+842
+8% +$17.8K
COLB icon
915
Columbia Banking Systems
COLB
$8.71B
$242K ﹤0.01%
+7,548
New +$224K
MRNA icon
916
Moderna
MRNA
$58.1B
$241K ﹤0.01%
+3,444
New +$178K
RCKT icon
917
Rocket Pharmaceuticals
RCKT
$424M
$241K ﹤0.01%
70,405
-18,596
-21% -$61.8K
WDAY icon
918
Workday
WDAY
$47.2B
$240K ﹤0.01%
1,960
-59
-3% -$7.47K
VMRK
919
Vivmark Residential
VMRK
$50.6B
$240K ﹤0.01%
+3,528
New +$228K
ZS icon
920
Zscaler
ZS
$27.7B
$239K ﹤0.01%
1,694
-268
-14% -$37.4K
AVTR icon
921
Avantor
AVTR
$10.1B
$239K ﹤0.01%
+24,103
New +$207K
NVR icon
922
NVR
NVR
$16.8B
$238K ﹤0.01%
35
IBP icon
923
Installed Building Products
IBP
$6.34B
$238K ﹤0.01%
1,037
+28
+3% +$6.8K
MFC icon
924
Manulife Financial
MFC
$73.5B
$238K ﹤0.01%
+5,875
New +$227K
WRBY icon
925
Warby Parker
WRBY
$3.01B
$238K ﹤0.01%
+7,830
New +$194K

Similar funds

Ballentine Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Ballentine Partners held 1,129 positions worth $8.18B, up 14% from $7.18B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Ballentine Partners's Q2 2026 filing shows 115 new, 553 increased, 336 reduced and 51 closed positions. Its largest new stake was State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF: 16,992 shares worth $1.54M. The largest sale was Vanguard Morningstar Total Stock Market ETF, an estimated $30.8M.

By sector, the portfolio is most concentrated in Miscellaneous at 76% of assets, down from 77% a quarter earlier, followed by Technology and Financials.

  • Ballentine Partners's largest Q2 2026 buy was State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF: 16,992 shares worth $1.54M.
  • Ballentine Partners added most to iShares Core MSCI EAFE ETF in Q2 2026, an estimated $10.5M increase.
  • Ballentine Partners's biggest Q2 2026 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $30.8M.
  • Ballentine Partners fully exited ExxonMobil in Q2 2026, selling an estimated $9.92M.
  • Ballentine Partners's ten largest holdings make up 59% of its $8.18B portfolio in Q2 2026.
  • Ballentine Partners opened 115 new positions and closed 51 in Q2 2026.
  • Ballentine Partners's portfolio value rose 14% quarter-over-quarter to $8.18B.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.